Michael Geoffrey Jameson

Dr. Michael Geoffrey Jameson is a Medical Physics researcher at the University of New South Wales, Medicine & Health faculty, based at St Vincent's Clinical School. His work focuses on improving radiotherapy accuracy and precision through innovative research across the entire treatment planning and delivery process.

Education:

• Ph.D., University of Wollongong, NSW, Australia (2016)
• B.Med.Rad.Phys (hons1), University of Wollongong, NSW, Australia (2007)

His research interests center on Medical Physics, Radiation Oncology, MRI applications, Image Processing, Radiation Dosimetry, and 3D Printing. Dr. Jameson has made significant contributions to understanding uncertainties in target delineation and has co-invented The HexaCheck medical device, now licensed to Standard Imaging Inc. His publications demonstrate a strong focus on adaptive radiotherapy, particularly for brain cancer treatment, with an emphasis on integrating MRI technology to improve treatment accuracy.

Scientific Recognition:

• Cancer Institute NSW Early Career Fellowship recipient
• NHMRC Program Grant recipient
• Associate Editor, Australasian Physical & Engineering Sciences in Medicine (since 2014)

Dr. Jameson serves as Principal Investigator on multiple research projects including the INTREPID trial for brain cancer outcomes and has secured significant funding from Cancer Institute NSW, NHMRC, and UNSW. His professional affiliations include the Australasian College of Physical Scientists and Engineers in Medicine, Australian Institute of Physics, American Association of Physicists in Medicine, and Trans-Tasman Radiation Oncology Group.